JP Morgan Chase’s OptiNose OPTN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-431
| Closed | -$3.95K | – | 7494 |
|
|
2025
Q1 | $3.95K | Sell |
431
-18
| -4% | -$113 | ﹤0.01% | 6463 |
|
|
2024
Q4 | $3K | Sell |
449
-19
| -4% | -$167 | ﹤0.01% | 6585 |
|
|
2024
Q3 | $4.7K | Sell |
468
-62
| -12% | -$904 | ﹤0.01% | 6499 |
|
|
2024
Q2 | $8.26K | Sell |
530
-7,960
| -94% | -$133K | ﹤0.01% | 6292 |
|
|
2024
Q1 | $186K | Buy |
8,490
+5,070
| +148% | +$113K | ﹤0.01% | 5391 |
|
|
2023
Q4 | $66.2K | Sell |
3,420
-1,353
| -28% | -$24.7K | ﹤0.01% | 5905 |
|
|
2023
Q3 | $88.1K | Buy |
4,773
+442
| +10% | +$7.96K | ﹤0.01% | 5559 |
|
|
2023
Q2 | $79.9K | Buy |
4,331
+2,973
| +219% | +$70.3K | ﹤0.01% | 5559 |
|
|
2023
Q1 | $39K | Buy |
1,358
+304
| +29% | +$8.09K | ﹤0.01% | 5796 |
|
|
2022
Q4 | $29K | Buy |
1,054
+667
| +172% | +$25.3K | ﹤0.01% | 5767 |
|
|
2022
Q3 | $21K | Buy |
387
+142
| +58% | +$7.79K | ﹤0.01% | 5792 |
|
|
2022
Q2 | $13K | Sell |
245
-407
| -62% | -$15K | ﹤0.01% | 5987 |
|
|
2022
Q1 | $24K | Buy |
652
+165
| +34% | +$5.89K | ﹤0.01% | 6034 |
|
|
2021
Q4 | $12K | Sell |
487
-1,226
| -72% | -$41K | ﹤0.01% | 6305 |
|
|
2021
Q3 | $77K | Sell |
1,713
-3,710
| -68% | -$156K | ﹤0.01% | 5692 |
|
|
2021
Q2 | $253K | Sell |
5,423
-2,617
| -33% | -$134K | ﹤0.01% | 5111 |
|
|
2021
Q1 | $445K | Sell |
8,040
-1,159
| -13% | -$70.5K | ﹤0.01% | 4746 |
|
|
2020
Q4 | $571K | Buy |
9,199
+8,330
| +959% | +$510K | ﹤0.01% | 4291 |
|
|
2020
Q3 | $50K | Sell |
869
-569
| -40% | -$42.1K | ﹤0.01% | 4933 |
|
|
2020
Q2 | $161K | Sell |
1,438
-194,711
| -99% | -$13.9M | ﹤0.01% | 4363 |
|
|
2020
Q1 | $13.2M | Buy |
196,149
+1,830
| +0.9% | +$184K | ﹤0.01% | 1518 |
|
|
2019
Q4 | $26.9M | Buy |
194,319
+4,261
| +2% | +$553K | 0.01% | 1360 |
|
|
2019
Q3 | $20M | Buy |
190,058
+12,210
| +7% | +$1.22M | ﹤0.01% | 1582 |
|
|
2019
Q2 | $17.1M | Buy |
177,848
+10,917
| +7% | +$1.44M | ﹤0.01% | 1687 |
|
|
2019
Q1 | $25.8M | Buy |
166,931
+12,478
| +8% | +$1.45M | 0.01% | 1367 |
|
|
2018
Q4 | $14.4M | Buy |
154,453
+29,504
| +24% | +$4.21M | ﹤0.01% | 1737 |
|
|
2018
Q3 | $23.3M | Buy |
124,949
+35,100
| +39% | +$10M | ﹤0.01% | 1548 |
|
|
2018
Q2 | $37.7M | Buy |
89,849
+89,776
| +122,981% | +$30.3M | 0.01% | 1142 |
|
|
2018
Q1 | $22K | Sell |
73
-5
| -6% | -$1.39K | ﹤0.01% | 5063 |
|
|
2017
Q4 | $22K | Buy |
+78
| New | +$21.9K | ﹤0.01% | 5146 |
|
JP Morgan Chase's OPTN Position: Q2 2025 in Review
JP Morgan Chase sold out of OptiNose (OPTN) in Q2 2025, closing a stake of 431 shares — an estimated $3.95K sold.
JP Morgan Chase first reported a position in OPTN in Q4 2017 and held it in 30 quarters. The position peaked at $37.7M in Q2 2018. 0 funds tracked by Wall St. Rank hold OPTN as of Q2 2025.
- JP Morgan Chase reported no remaining OptiNose position as of Q2 2025 after selling out during the quarter.
- JP Morgan Chase sold 431 OptiNose shares in Q2 2025, an estimated $3.95K.
- JP Morgan Chase first reported a position in OptiNose in Q4 2017 and held it in 30 quarters.
- JP Morgan Chase's OptiNose position peaked at $37.7M in Q2 2018.
- 0 funds tracked by Wall St. Rank held OptiNose as of Q2 2025.
Based on JP Morgan Chase's 13F filing for Q2 2025, filed 12 Aug 2025.